Papers

Peer-reviewed International journal
Feb, 2019

Effect of an enhanced recovery after surgery protocol in patients undergoing pancreaticoduodenectomy: A randomized controlled trial.

Clinical nutrition (Edinburgh, Scotland)
  • Kosei Takagi
  • Ryuichi Yoshida
  • Takahito Yagi
  • Yuzo Umeda
  • Daisuke Nobuoka
  • Takashi Kuise
  • Shiro Hinotsu
  • Takashi Matsusaki
  • Hiroshi Morimatsu
  • Jun Eguchi
  • Jun Wada
  • Masuo Senda
  • Toshiyoshi Fujiwara
  • Display all

Volume
38
Number
1
First page
174
Last page
181
Language
English
Publishing type
Research paper (scientific journal)
DOI
10.1016/j.clnu.2018.01.002

BACKGROUND & AIMS: Evidence of the advantages of enhanced recovery after surgery (ERAS) protocols following pancreaticoduodenectomy (PD) is limited. The aim of this study was to examine the efficiency of ERAS protocols in patients following PD. METHODS: Between June 2014 and October 2016, patients undergoing PD were randomly assigned to receive ERAS protocols or standard care. The primary endpoint was the postoperative length of stay. Secondary endpoints included postoperative complications, postoperative quality-of-life (QoR-40J), readmission, and medical cost. RESULTS: Of 80 eligible patients, 74 were analyzed in intention-to-treat principles: 37 in the control group and 37 in the ERAS group. The mean length of stay in the ERAS group was significantly shorter than that in the control group (20.1 ± 5.4 vs 26.9 ± 13.5 days, P < 0.001). The ERAS group had a significantly lower percentage of postoperative complications (32.4% vs 56.8%, P = 0.034) and readmissions (0% vs 8.1%, P = 0.038). Quality-of-life was also significantly better in the ERAS group (184 ± 12.4 vs 177 ± 14.5, P = 0.022). The total medical cost was lower in the ERAS group, but not significantly ($25,445 ± 5065 vs $28,384 ± 9999, P = 0.085). CONCLUSIONS: The optimization of ERAS protocols in patients undergoing PD is safe and accelerates perioperative recovery and quality-of-life, thereby reducing the length of stay. Morbidity was significantly decreased in the ERAS group without compromising surgical outcome. REGISTRATION NUMBER: UMIN000014068.

Link information
DOI
https://doi.org/10.1016/j.clnu.2018.01.002
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/29373148
URL
http://orcid.org/0000-0003-1468-5170
ID information
  • DOI : 10.1016/j.clnu.2018.01.002
  • ORCID - Put Code : 43365841
  • Pubmed ID : 29373148

Export
BibTeX RIS